(6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one

C25H26FN3O4 — CID 58109474

IUPAC(6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one
SMILESC[C@@H](c1ccc(-c2ccc(=O)[nH]n2)cc1)N1CC[C@](CCCO)(c2ccc(F)cc2)OC1=O
InChIInChI=1S/C25H26FN3O4/c1-17(18-3-5-19(6-4-18)22-11-12-23(31)28-27-22)29-15-14-25(13-2-16-30,33-24(29)32)20-7-9-21(26)10-8-20/h3-12,17,30H,2,13-16H2,1H3,(H,28,31)/t17-,25+/m0/s1
InChIKeyKBXHOFLTZOWQQD-SSOJOUAXSA-N
MW451.50 g/mol
LogP4.15
Rot. Bonds7

About (6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one

(6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one (PubChem CID 58109474) has the molecular formula C25H26FN3O4 and a molecular weight of 451.50 g/mol. Its IUPAC name is (6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one.

Molecular Properties

Compound Name(6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one
PubChem CID58109474
Molecular FormulaC25H26FN3O4
Molecular Weight451.50 g/mol
Exact Mass451.19
IUPAC Name(6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one
SMILESC[C@@H](c1ccc(-c2ccc(=O)[nH]n2)cc1)N1CC[C@](CCCO)(c2ccc(F)cc2)OC1=O
InChIInChI=1S/C25H26FN3O4/c1-17(18-3-5-19(6-4-18)22-11-12-23(31)28-27-22)29-15-14-25(13-2-16-30,33-24(29)32)20-7-9-21(26)10-8-20/h3-12,17,30H,2,13-16H2,1H3,(H,28,31)/t17-,25+/m0/s1
InChIKeyKBXHOFLTZOWQQD-SSOJOUAXSA-N
XLogP4.15
TPSA95.52 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500451.50
LogP ≤ 54.15
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze (6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one?
The IUPAC name of (6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one (CID 58109474) is (6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one.
What is the SMILES notation for (6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one?
The canonical SMILES for (6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one is C[C@@H](c1ccc(-c2ccc(=O)[nH]n2)cc1)N1CC[C@](CCCO)(c2ccc(F)cc2)OC1=O.
What is the InChIKey of (6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one?
The InChIKey is KBXHOFLTZOWQQD-SSOJOUAXSA-N. The full InChI is InChI=1S/C25H26FN3O4/c1-17(18-3-5-19(6-4-18)22-11-12-23(31)28-27-22)29-15-14-25(13-2-16-30,33-24(29)32)20-7-9-21(26)10-8-20/h3-12,17,30H,2,13-16H2,1H3,(H,28,31)/t17-,25+/m0/s1.
What are the key properties of (6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one?
(6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one has a molecular weight of 451.50 g/mol, XLogP of 4.15, 7 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (6R)-6-(4-fluorophenyl)-6-(3-hydroxypropyl)-3-[(1S)-1-[4-(6-oxo-1H-pyridazin-3-yl)phenyl]ethyl]-1,3-oxazinan-2-one is sourced from PubChem (CID 58109474), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).